Published in Cancer Weekly, May 19th, 2009
"Patients were included in this study when they had a skin lesion on the head which was clinically consistent with the diagnosis of BCC. FD was performed using a 20% 5-aminolaevulinic acid (ALA) cream. The FD tumor area...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.